# Incyte (INCY) — Analyst Forecast

INCY · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/incy/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 13 | 16 | 2 | 31 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $104.00 | $134.71 | $157.00 | 14 |

Last price $113.27 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 14, 2026 | Truist Securities | Maintained | Hold | $115.00 |
| Oct 13, 2026 | HC Wainwright & Co. | Maintained | Buy | $152.00 |
| Oct 8, 2026 | RBC Capital | Maintained | Sector Perform | $114.00 |
| Oct 5, 2026 | Stifel | Maintained | Buy | $157.00 |
| Oct 1, 2026 | Wells Fargo | Maintained | Equal-Weight | $128.00 |
| Sep 28, 2026 | HC Wainwright & Co. | Maintained | Buy | $152.00 |
| Sep 28, 2026 | JP Morgan | Maintained | Neutral | $123.00 |
| Sep 22, 2026 | RBC Capital | Maintained | Sector Perform | $109.00 |
| Aug 20, 2026 | HC Wainwright & Co. | Maintained | Buy | $150.00 |
| Aug 20, 2026 | Canaccord Genuity | Initiated Coverage | Buy | $152.00 |
| Aug 17, 2026 | Piper Sandler | Maintained | Overweight | $130.00 |
| Aug 4, 2026 | Mizuho | Maintained | Outperform | $137.00 |
| Aug 3, 2026 | HC Wainwright & Co. | Maintained | Buy | $150.00 |
| Aug 3, 2026 | Leerink Partners | Maintained | Outperform | $155.00 |
| Jul 29, 2026 | HC Wainwright & Co. | Maintained | Buy | $150.00 |
| Jul 29, 2026 | Barclays | Maintained | Overweight | $139.00 |
| Jul 29, 2026 | Guggenheim | Maintained | Buy | $150.00 |
| Jul 29, 2026 | BMO Capital | Maintained | Market Perform | $130.00 |
| Jul 29, 2026 | RBC Capital | Maintained | Sector Perform | $109.00 |
| Jul 23, 2026 | Morgan Stanley | Maintained | Equal-Weight | $104.00 |

## Frequently Asked Questions

### What is the price target for INCY stock?

The average 12-month analyst price target for Incyte (INCY) is $134.71, with a high estimate of $157.00 and a low of $104.00, across 14 analysts.

### Is INCY a buy, sell, or hold?

Analysts covering Incyte currently average a Hold rating: 13 buy, 16 hold and 2 sell, from 31 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for INCY?

The average price target of $134.71 implies 18.93% upside from the last price of $113.27.

### What is the latest analyst rating on INCY?

On Oct 14, 2026, Truist Securities maintained Incyte at Hold with a price target of $115.00.

## Similar Stocks

- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).